METICORTELONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meticortelone, and what generic alternatives are available?
Meticortelone is a drug marketed by Schering and is included in one NDA.
The generic ingredient in METICORTELONE is prednisolone acetate. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meticortelone
A generic version of METICORTELONE was approved as prednisolone acetate by LUPIN on August 2nd, 2024.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METICORTELONE?
- What are the global sales for METICORTELONE?
- What is Average Wholesale Price for METICORTELONE?
Summary for METICORTELONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Clinical Trials: | 10 |
| Patent Applications: | 4,411 |
| DailyMed Link: | METICORTELONE at DailyMed |
Recent Clinical Trials for METICORTELONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| Children's Oncology Group | Phase 1/Phase 2 |
| National Cancer Institute (NCI) | Phase 1/Phase 2 |
US Patents and Regulatory Information for METICORTELONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | METICORTELONE | prednisolone acetate | INJECTABLE;INJECTION | 010255-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
